Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Melanoma

  Free Subscription


1 Ann Surg Oncol
1 Br J Dermatol
1 Cancer
1 Clin Exp Metastasis
1 Int J Cancer
1 Lancet
1 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

    Let's Not Forget About Regional Therapy for the Treatment of Locally Advanced Extremity Melanoma.
    Ann Surg Oncol. 2019 May 6. pii: 10.1245/s10434-019-07430.
    PubMed     Text format    

    Br J Dermatol

  2. ELLIS R, Tang D, Nasr B, Greenwood A, et al
    Epidermal AMBRA1 and Loricrin; a paradigm shift in the prognostication and stratification of AJCC stage I melanomas.
    Br J Dermatol. 2019 May 6. doi: 10.1111/bjd.18086.
    PubMed     Text format     Abstract available


  3. NAJJAR YG, Puligandla M, Lee SJ, Kirkwood JM, et al
    An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanoma.
    Cancer. 2019 May 8. doi: 10.1002/cncr.32162.
    PubMed     Text format     Abstract available

    Clin Exp Metastasis

  4. SINGH MK, Singh L, Pushker N, Saini N, et al
    Identification of canonical NFkappaB (C-NFkappaB) pathway in uveal melanoma and their relation with patient outcome.
    Clin Exp Metastasis. 2019 May 8. pii: 10.1007/s10585-019-09969.
    PubMed     Text format     Abstract available

    Int J Cancer

  5. MOREIRA A, Gross S, Kirchberger MC, Erdmann M, et al
    Senescence markers: Predictive for response to checkpoint inhibitors.
    Int J Cancer. 2019;144:1147-1150.
    PubMed     Text format     Abstract available


  6. JANUSZEWICZ W, Corrie P, Liu H, Chan J, et al
    A sinister black finding in the stomach.
    Lancet. 2019;393:1149.
    PubMed     Text format    

    N Engl J Med

  7. EVERETT L, Copperman T
    Metastatic Uveal Melanoma.
    N Engl J Med. 2019;380:1853.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.